A detailed history of Atwater Malick LLC transactions in Danaher Corp stock. As of the latest transaction made, Atwater Malick LLC holds 1,640 shares of DHR stock, worth $394,272. This represents 0.14% of its overall portfolio holdings.

Number of Shares
1,640
Previous 1,501 9.26%
Holding current value
$394,272
Previous $347,000 17.87%
% of portfolio
0.14%
Previous 0.14%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

BUY
$224.58 - $256.19 $31,216 - $35,610
139 Added 9.26%
1,640 $409,000
Q4 2023

Jan 11, 2024

SELL
$185.1 - $233.13 $10,365 - $13,055
-56 Reduced 3.6%
1,501 $347,000
Q3 2023

Oct 17, 2023

SELL
$233.08 - $265.59 $41,954 - $47,806
-180 Reduced 10.36%
1,557 $386,000
Q2 2023

Jul 17, 2023

BUY
$224.99 - $256.14 $10,124 - $11,526
45 Added 2.66%
1,737 $416,000
Q1 2023

Apr 19, 2023

BUY
$239.75 - $277.0 $6,713 - $7,756
28 Added 1.68%
1,692 $426,000
Q4 2022

Feb 14, 2023

BUY
$241.42 - $282.29 $401,722 - $469,730
1,664 New
1,664 $441,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $175B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Atwater Malick LLC Portfolio

Follow Atwater Malick LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atwater Malick LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atwater Malick LLC with notifications on news.